Genmab (NASDAQ:GMAB), a biotechnology company with a market capitalization of $16.91 billion specializing in cancer ...

Harmony Biosciences Holdings, Inc.'s strong revenue growth, diverse pipeline, and undervalued stock make it a compelling buy.

Researchers say neuromorphic systems are reaching a “critical juncture,” with scale being a key metric to track the progress ...

Scientists from the Massachusetts Institute of Technology (MIT) have developed advanced robotic insects that could aid ...

Binance Labs rebrands to YZi Labs, focusing on Web3, AI, and biotech with CZ mentoring startups and Ella Zhang at the helm.

A new report dives into the evolving clinical trial landscape and transformative therapies changing lives for bladder cancer ...

Tilt your stock portfolio toward biotech companies now and you could stand to make substantial profits in the near future. You can also find cost-effective stocks under $20 to trade daily on the ...

Rebuilding global trust needs empathy-driven, collective leadership and reformed education to prepare future leaders for ...

Industry leaders are hopeful that DEI will remain a priority for enhanced audience engagement, but fear that it will not stay ...

Leading internationally-experienced sports nutritionist joins the Company's growing team to expand its sports vertical. NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited ...

We predicted that during the course of this year, it would start to stabilise. We would see the beginnings recovery in that ...

Fidelity Select Biotechnology Portfolio earns an Above Average Process Pillar rating. The main driver of the rating is its parent firm's excellent long-term risk-adjusted performance, as shown by ...